‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
Search
Filter
Clear All121-140 of 143 results
-
-
‘How Long Have I Got, Doc?’ Why Many Cancer Patients Don’t Have Answers
Due to poor doctor-patient communication, most people with advanced cancer don’t know enough about their disease to make vital decisions.
By Liz Szabo -
Depression Among Heart Attack Survivors Can Be Deadly, Yet Is Often Ignored
One in 5 heart attack patients suffers from severe depression, yet many get little or no treatment that could ease their suffering or save their lives.
By Liz Szabo -
REPEAL & REPLACE WATCH
Senate GOP Bill Aims To Add Psych Beds; Squeeze On Medicaid Signals Their Undoing
The Senate health care bill has a provision to increase hospital beds for psychiatric care, but overall cuts in Medicaid could lead to even fewer beds nationwide.
By Liz Szabo -
TREATING CANCER: HOPE VS. HYPE
Widespread Hype Gives False Hope To Many Cancer Patients
Doctors and drug developers have a stake in making cancer treatments seem better than they really are.
By Liz Szabo -
As Government-Funded Cancer Research Sags, Scientists Fear U.S. Is ‘Losing Its Edge’
More of the research studies being presented at the world’s largest annual gathering of cancer scientists comes from abroad.
By Liz Szabo -
Treating Cancer: Hope Vs. Hype
Sticker Shock Forces Thousands Of Cancer Patients To Skip Drugs, Skimp On Treatment
A growing number of patients fail to fill prescriptions because the cost of cancer drugs is too high.
By Liz Szabo -
Treating Cancer: Hope Vs. Hype
Dozens Of New Cancer Drugs Do Little To Improve Survival, Frustrating Patients
The FDA has approved dozens of new cancer medications in recent years, but few offer the benefits that patients seek.
By Liz Szabo -
Cholesterol Drug Prevents Heart Attacks — But It Doesn’t Come Cheap
A cholesterol-lowering drug called Repatha cuts the risk of heart attacks, strokes and heart-related death by 20 percent, according to a new study.
By Liz Szabo -
One In Three Women With Breast Cancer Treated Unnecessarily, Study Concludes
Mammograms find many slow-growing cancers that aren’t life-threatening and shouldn’t be treated, a Danish study said.
By Liz Szabo -
Social Isolation May Worsen Breast Cancer Prospects
A new study shows women fare worse without a support network.
By Liz Szabo -
Senate Approves Landmark Mental Health Bill As Part Of 21st Century Cures Act
The U.S. Senate passed a landmark bill to help millions of Americans suffering from mental illness.
By Liz Szabo -
Legislation To Improve Mental Health Care For Millions Sails Through House Vote
Sponsors of Congressional action up for vote Wednesday have championed mental health changes since the 2012 Newtown shootings.
By Liz Szabo -
Clinics Help Keep People With Serious Mental Illness Out Of ER
Providing regular care at a Texas clinic prevents patients from cycling back to the hospital in a psychiatric crisis.
By Liz Szabo -
Dementia Rates Decline Sharply Among Senior Citizens
Education and better heart health may deserve credit.
By Liz Szabo -
Deadly Superbug Linked To Four Deaths In The U.S.
A deadly superbug has been linked to at least four deaths and nine other cases in the U.S. and has spread across the globe in just six years.
By Liz Szabo -
Terminally Ill Patients Don’t Use Aid-In-Dying Laws To Relieve Pain
Ending pain and suffering has helped several states pass “right-to-die” laws, but dying patients are more concerned about controlling how they die and dying with dignity.
By Liz Szabo -
Young Boy’s Struggle To Survive Sparked Push For Drugs For Terminally Ill
Ten-year-old Josh Hardy died last month. His struggle to survive helped to spur laws to get unapproved drugs to the terminally ill.
By Liz Szabo -
FDA Approves First Drug To Treat Rare Form Of Muscular Dystrophy
The FDA, reacting to lobbying by patients and families, has approved a drug for Duchenne muscular dystrophy, a rare and lethal disease.
By Liz Szabo -
Alleged Scheme To Fix Generic Drug Prices Started At Dinners And ‘Girls Nights Out’
Investigators claim drugmaker employees met in secret at restaurants, golf outings and at “Girls Night Out” to raise generic drug prices.